OmniaBio Inc is Canada's largest cell and gene therapy CDMO, established by CCRM in 2022. The company provides end-to-end contract development and manufacturing services for autologous and allogeneic cell therapies, lentiviral vectors, and immunotherapies. Its Hamilton, Ontario facility integrates AI, automation, and robotics to enhance manufacturing efficiency and reduce costs.
autologous cell therapy manufacturing, allogeneic cell therapy, lentiviral vector production, iPSC-based therapies, AI-enabled GMP manufacturing
1 site worldwide
No reviews available yet.
No documents available.